Effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid gel supplementation on muscle mass, strength, and power in resistance trained individuals

KA Dunsmore,Ryan P. Lowery,N. Duncan,G. Davis,J. Rathmacher,SM Baier,EM Sikorski,TJ Morrison,M. Naimo,J. Walters,Stephanie M. C. Wilson,Jacob M. Wilson

DOI: https://doi.org/10.1186/1550-2783-9-S1-P5

2012-11-19

Journal of the International Society of Sports Nutrition

Abstract:

What problem does this paper attempt to address?

DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.

D. Phillips

Abstract:
Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report

Sandeep Kumar,Rohit Bansal,Priya Bansal,Rajinder Kumar Dhamija,Dnb Neurology

DOI: https://doi.org/10.7812/TPP/19.088

Abstract:Introduction: Drug-induced immune hemolytic anemia (DIIHA) is a rare complication of any drug therapy, which if not recognized early can be fatal. It is usually underdiagnosed. Ceftriaxone is a commonly used antibiotic in routine practice and is one of the most common drugs to cause DIIHA. Case presentation: We report a case of ceftriaxone-induced immune hemolytic anemia in a 62-year-old woman who had a negative result of a direct antiglobulin test. Discussion: A review of the literature highlights the salient features of DIIHA and underscores the importance of keeping the suspicion of DIIHA high in the relevant clinical settings because ceftriaxone has been associated with particularly severe outcomes of DIIHA. In cases of unclear hemolysis and despite a negative result of a direct antiglobulin test, the treating physician must keep suspicion of DIIHA high and meticulously look for the possible culprit drugs. Treatment with suspected drugs must be stopped promptly to prevent severe complications and fatal outcomes.
Model studies of hydrogen atom addition and abstraction processes involving ortho-, meta-, and para-benzynes.

A. Clark,E. Davidson

DOI: https://doi.org/10.1021/JA0159620

IF: 15

2001-10-04

Journal of the American Chemical Society

Abstract:H-atom addition and abstraction processes involving ortho-, meta-, and para-benzyne have been investigated by multiconfigurational self-consistent field methods. The H(A) + H(B)...H(C) reaction (where r(BC) is adjusted to mimic the appropriate singlet-triplet energy gap) is shown to effectively model H-atom addition to benzyne. The doublet multiconfiguration wave functions are shown to mix the "singlet" and "triplet" valence bond structures of H(B)...H(C) along the reaction coordinate; however, the extent of mixing is dependent on the singlet-triplet energy gap (DeltaE(ST)) of the H(B)...H(C) diradical. Early in the reaction, the ground-state wave function is essentially the "singlet" VB function, yet it gains significant "triplet" VB character along the reaction coordinate that allows H(A)-H(B) bond formation. Conversely, the wave function of the first excited state is predominantly the "triplet" VB configuration early in the reaction coordinate, but gains "singlet" VB character when the H-atom is close to a radical center. As a result, the potential energy surface (PES) for H-atom addition to triplet H(B)...H(C) diradical is repulsive! The H3 model predicts, in agreement with the actual calculations on benzyne, that the singlet diradical electrons are not coupled strongly enough to give rise to an activation barrier associated with C-H bond formation. Moreover, this model predicts that the PES for H-atom addition to triplet benzyne will be characterized by a repulsive curve early in the reaction coordinate, followed by a potential avoided crossing with the (pi)1(sigma*)1 state of the phenyl radical. In contrast to H-atom addition, large activation barriers characterize the abstraction process in both the singlet ground state and first triplet state. In the ground state, this barrier results from the weakly avoided crossing of the dominant VB configurations in the ground-state singlet (S0) and first excited singlet (S1) because of the large energy gap between S0 and S1 early in the reaction coordinate. Because the S1 state is best described as the combination of the triplet X-H bond and the triplet H(B)...H(C) spin couplings, the activation barrier along the S0 abstraction PES will have much less dependence on the DeltaE(ST) of H(B)...H(C) than previously speculated. For similar reasons, the T1 potential surface is quite comparable to the S0 PES.
Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness

James Tasch,Pedro Gonzalez-Zayaz

DOI: https://doi.org/10.12659/AJCR.903507

2017-04-21

Abstract:BACKGROUND Drug-induced immune hemolytic anemia (DIIHA) is a rare condition that may result from the administration of an antibiotic, most notably the cephalosporin class, commonly used in both the adult and pediatric populations. A delay in recognition by a provider may lead to continuation of the offending agent and possibly result in fatal outcomes. CASE REPORT We report the case of a 65-year-old woman on ceftriaxone infusions after being diagnosed with acute mitral valve endocarditis 3 weeks prior, which presented with severe anemia and bilateral transient vision loss. Being a Jehovah's Witness, the patient refused blood product transfusions and was managed with alternative therapies. The etiology of the symptoms was suspected to be a hemolytic anemia directly related to her ceftriaxone infusions. CONCLUSIONS This report demonstrates the importance of close vigilance while prescribing drugs known to cause hemolytic anemia. Although rare, drug-induced immune hemolytic anemia caused by ceftriaxone may be a potentially fatal condition, but with early recognition and withdrawal of the offending agent, successful treatment may ensue. Serological tests should be utilized to obtain a definitive diagnosis.
Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

Hans Benno Leicht,Elke Weinig,Beate Mayer,Johannes Viebahn,Andreas Geier,Monika Rau

DOI: https://doi.org/10.1186/s40360-018-0257-7

2018-10-25

Abstract:Background: Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most common drugs causing DIIHA, and ceftriaxone-induced immune hemolytic anemia (IHA) has especially been reported to cause severe complications and fatal outcomes. Case presentation: A 76-year-old male patient was treated with ceftriaxone for cholangitis. Short time after antibiotic exposure the patient was referred to intensive care unit due to cardiopulmonary instability. Hemolysis was observed on laboratory testing and the patient developed severe renal failure with a need for hemodialysis for 2 weeks. Medical history revealed that the patient had been previously exposed to ceftriaxone less than 3 weeks before with subsequent hemolytic reaction. Further causes for hemolytic anemia were excluded and drug-induced immune hemolytic (DIIHA) anemia to ceftriaxone could be confirmed. Conclusions: The case demonstrates the severity of ceftriaxone-induced immune hemolytic anemia, a rare, but immediately life-threatening condition of a frequently used antibiotic in clinical practice. Early and correct diagnosis of DIIHA is crucial, as immediate withdrawal of the causative drug is essential for the patient prognosis. Thus, awareness for this complication must be raised among treating physicians.
A Unified DAQ Interconnection Network With Precise Time Synchronization

F. Lemke,David Slogsnat,N. Burkhardt,U. Bruening

DOI: https://doi.org/10.1109/TNS.2010.2042176

IF: 1.703

2010-04-12

IEEE Transactions on Nuclear Science

Abstract:This paper focuses on the interconnection network used as a part of the Data Acquisition System of the Compressed Baryonic Matter experiment at the Facility for Antiproton and Ion Research in Darmstadt, Germany. This experiment will have special demands on the Data Acquisition System like limited space for hardware, radiation tolerance, flexibility for different types of network traffic and support for synchronization mechanisms. The specialty of the CBM network is that it uses only a single bidirectional fiber link for all network abilities and providing a deterministic latency message for precise time synchronisation. This led to the development of a new network and protocol.
Cefazolin-induced hemolytic anemia in septic arthritis: A case report

S Jawad Zafar,Zachary Wynne,Thomas John,Lauren Groft Buzzalino,Akira A Shishido,David J Riedel

DOI: https://doi.org/10.1016/j.idcr.2024.e02057

2024-08-09

IDCases

Abstract:A 50-year-old woman living with untreated HIV and injection drug use presented with right shoulder pain. The shoulder exam and computed tomography (CT) scan were concerning for septic arthritis. She was started on empiric vancomycin and cefepime and underwent right shoulder debridement and humeral head resection. Bone cultures grew methicillin sensitive Staphylococcus aureus (MSSA); empiric broad-spectrum antibiotics were changed to cefazolin. The patient subsequently developed severe anemia refractory to blood transfusions approximately 6 days later. Further evaluation disclosed hemolytic anemia attributable to cefazolin. Antibiotic therapy was switched from cefazolin to daptomycin, and the patient was started on prednisone. She had sustained improvement in hemoglobin values above 6 g/dL without requiring further transfusions prior to hospital discharge. Drug-induced immune hemolytic anemia from cefazolin is rare but has been reported primarily in the perioperative setting. Here, we present a case following initiation of treatment for septic arthritis.
Simulation model for wide-area multi-service passive radar coverage predictions

W. Barott,B. Himed

DOI: https://doi.org/10.1109/RADAR.2013.6586131

2013-09-09

Abstract:This paper describes the simulation approach and model for a software tool used to analyze passive radar scenarios. A database of known transmitters includes more than 250,000 sources from FM radio, digital television, cellular, and aeronautical radio-navigation aids. Terrain is considered using digital elevation maps and the Irregular Terrain Model. The tool calculates the expected detection and localization performance for PBR receivers, and can be used to guide receiver design.
AD-A 201 35 0 Distribution Unlimited

T. Cebeci,Wenhan,Su

Abstract:Results are presented to describe the laminar flow patterns around a prolate spheroid at angles of attack of 1, 2, 3, and 30 degrees and complement those obtained previously at 6 degrees. They were obtained by solving threedimensional boundary-layer equations with a combination of standard and characteristic box methods and with a stability criterion to ensure numerical accuracy. Emphasis Is placed on the nature of separation which, In agreement with experiment but contrary to some theoretical claims, is shown to be open for all angles of attack and to be coincident with a particular skin friction line.
[Surgical repair of secondary local defect after auricular reconstruction].

Bo Pan,H. Zhuang,Zhen Cai

2007-12-01

Abstract:
Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

Yuanjun Wu,Yong Wu,Yanli Ji,Jiajie Liang,Ziyi He,Yanhui Liu,Li Tang,Ganping Guo

DOI: https://doi.org/10.3389/fmed.2021.697192

IF: 3.9

2021-08-12

Frontiers in Medicine

Abstract:There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia. To date, no serological evidence has been reported to suggest that cefoperazone can lead to drug-induced immune haemolytic anaemia (DIIHA). This report aims to fill these gaps in knowledge by describing a case of DIIHA caused by cefoperazone-dependent antibodies. A 59-year-old man developed fatal haemolytic anaemia while receiving cefoperazone-tazobactam or cefoperazone-sulbactam for the treatment of a lung infection that occurred after craniocerebral surgery. This eventually led to renal function impairment. Prior to the discontinuation of cefoperazone treatment, the patient showed strong positive (4+) results for both anti-IgG and anti-C3d direct antiglobulin test (DAT), while cefoperazone-dependent IgM and IgG antibodies were detected. The patient's plasma and O-type RBCs were incubated with tazobactam or sulbactam solution at 37°C for 3 h, the results of DAT for anti-IgG and anti-C3d were both positive. Forty-three days after the discontinuation of cefoperazone, the results of DAT for anti-IgG and anti-C3d were negative. Meanwhile incubation of the patient's fresh serum and his own RBCs with cefoperazone at 37°C, gave rise to mild haemolysis, and the results of DAT for both anti-IgG and anti-C3d were positive. It is suggested that cefoperazone-dependent antibodies can activate complement, and the non-immunologic protein adsorption effect of tazobactam or sulbactam can enhance IgG and complement binding to RBCs. This may promote the formation of immunocomplexes and complement activation, thereby aggravating haemolysis.

medicine, general & internal
[Drug-induced immune hemolytic anemia caused by cefmetazole]

Natsuki Shioji,Minoru Mizutani,Mariko Okayama,Haruna Katayama,Eiko Ooya,Takao Sekine,Masahiro Masuya

DOI: https://doi.org/10.11406/rinketsu.59.884

Abstract:A 56-year-old female who was diagnosed with acute calculous cholecystitis received intravenous administration of cefmetazole (CMZ) from the day of admission; she underwent laparoscopic cholecystectomy on the 13th hospital day. She was referred to our department because of hematuria that persisted for 3 days and progressive anemia on the day after the surgery. Laboratory data showed the following results: hemoglobin (Hb) level, 6.8 g/dl; reticulocyte count, 3.4%; serum lactate dehydrogenase, 1,505 IU/l; serum creatinine, 1.1 mg/dl; and undetectable haptoglobin. The direct globulin test showed that the patient was positive for IgG. Thus, drug-induced immune hemolytic anemia (DIIHA) was considered. All drugs, including CMZ, were immediately discontinued, and steroid was administered. The signs of hemolysis began to subside 3 days after the initiation of steroid therapy, and the administration of steroid was discontinued on the 5th day of the treatment. The patient's Hb level gradually increased, and the direct globulin test showed that the patient was negative for IgG on the 21st day from the onset of hematuria. Antibodies against CMZ-coated red blood cells were observed in the serum preserved at the onset of hemolysis. DIIHA is a rare but life-threatening disease. Immediate discontinuation of any suspected drugs and the initiation of steroid therapy as necessary are important in cases wherein DIIHA is suspected.
Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review

Enfu Tao,Huangjia Zhou,Meili Zheng,Yisha Zhao,Junfen Zhou,Junhui Yuan,Tianming Yuan,Changhua Zheng

DOI: https://doi.org/10.3389/fphar.2024.1362668

IF: 5.6

2024-03-15

Frontiers in Pharmacology

Abstract:Ceftriaxone is widely used in pediatric outpatient care for its efficacy against respiratory and digestive system infections, yet its increasing association with severe immune hemolytic reactions requires heightened vigilance from pediatricians. This report details a rare and severe case of ceftriaxone-induced severe immune hemolytic anemia (IHA), hemolytic crisis, myocardial injury, liver injury, renal calculi, and cholecystolithiasis in a previously healthy 3-year-old child. The child, treated for bronchitis, experienced sudden pallor, limb stiffness, and altered consciousness following the fifth day of ceftriaxone infusion, with hemoglobin (Hb) levels precipitously dropping to 21 g/L. Immediate cessation of ceftriaxone and the administration of oxygen therapy, blood transfusion, intravenous immunoglobulin (IVIG), and corticosteroids led to a gradual recovery. Despite initial improvements, the patient's condition necessitated extensive hospital care due to complications including myocardial injury, liver injury, renal calculi, and cholecystolithiasis. After a 12-day hospital stay and a 3-month follow-up, the child showed complete normalization of Hb and liver function and resolution of calculi. In children, ceftriaxone infusion may trigger severe, potentially fatal, hemolytic reactions. Pediatricians must promptly recognize symptoms such as pallor, limb stiffness, and unresponsiveness, indicative of ceftriaxone-induced severe IHA, and immediately discontinue the drug. Effective management includes timely blood transfusion, respiratory support, IVIG administration, and corticosteroids when necessary, along with rigorous vital signs monitoring. Continued vigilance is imperative, even after cessation of ceftriaxone, to promptly address any residual adverse effects.

pharmacology & pharmacy
Ceftriaxone-Induced Encephalopathy in a Patient With Chronic Kidney Disease

Ana Filipa Martins,Mónica Dias,Rita Matos Sousa,Maria João Regadas

DOI: https://doi.org/10.7759/cureus.54476

2024-02-19

Cureus

Abstract:Neurotoxicity is an acknowledged side effect of third and fourth-generation cephalosporins, but its occurrence with ceftriaxone is not widely recognized. This article presents a case involving a 56-year-old woman with multiple comorbidities who sought medical attention after experiencing lipothymia. The initial diagnosis suggested a urinary tract infection with acute kidney failure, leading to the initiation of ceftriaxone and hemodialysis. Subsequently, the patient exhibited a progressive deterioration of her neurological state, characterized by agitation and chorea. Metabolic encephalopathy, seizure/nonconvulsive status epilepticus, and acute central nervous system lesions were considered primary differential diagnoses, all of which were subsequently ruled out through thorough investigations. Days later, a remarkable recovery of the patient's neurological state was observed. A retrospective analysis revealed a correlation between the improvement and the fourth day of antimicrobial suspension. Consequently, a presumptive diagnosis of ceftriaxone-induced encephalopathy was made. This unusual case underscores the importance of recognizing the potential for pharmacological encephalopathy, particularly with ceftriaxone, and emphasizes its reversibility upon discontinuation of the implicated drug. Clinicians should remain vigilant to this uncommon adverse effect, promoting timely intervention and improved patient outcomes.
[Specialization in veterinary medicine].

E. Teske

1993-09-15

Abstract:
[Mesenteric cystic lymphangioma in children. Apropos of a case revealed by anemia].

G. Solovei,A. Alame,J. Elchardus,F. Glavier,J. Petit,P. Cart,J. Favriel,H. al Hareiss

Annales de Chirurgie

Abstract:A case of mesenteric cystic lymphangioma revealed by hypochromic anemia and abdominal pain, secondary to an intracystic hemorrhage is reported in a 4-year old child. Etiology, pathology, diagnosis, treatment and prognosis of mesenteric lymphangioma in children are reviewed.
Drug-induced immune haemolytic anaemia caused by levofloxacin

Shashvat Sukhal,Shweta Gupta

DOI: https://doi.org/10.11622/smedj.2014111

Abstract:Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of life-threatening DIIHA due to levofloxacin. This is the second case reported in the literature. A 51-year-old woman presented with complaints of fatigue after 4-5 days of levofloxacin therapy for a lung infection. At presentation, she was found to have haemolysis with a positive Coombs test and IgG autoantibodies. Levofloxacin was identified as the probable culprit, using the Naranjo adverse drug reaction probability scale. Upon discontinuation of the drug and initiation of steroids, the patient's haematological parameters stabilised. Diagnosis of DIIHA is made through a history of intake of levofloxacin, clinical and laboratory features of haemolysis and a positive Coombs test. An autoantibody screen is most commonly positive for warm antibodies (IgG type). It is essential for clinicians to recognise this rare complication caused by a commonly prescribed medication, discontinue the offending drug and initiate treatment.
Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use

Jillian Frieder,Jason Aboudi Mouabbi,Rami Zein,Tariq Hadid

DOI: https://doi.org/10.2146/ajhp160203

2017-06-15

Abstract:Purpose: A case report of drug-induced immune hemolytic anemia (DIIHA) triggered by exposure to trimethoprim-sulfamethoxazole is presented along with a brief review of the pathophysiology of DIIHA and diagnostic considerations. Summary: A 58-year-old woman recently initiated on trimethoprim-sulfamethoxazole for treatment of a urinary tract infection presented to the emergency department with generalized weakness and fatigue. Initial laboratory studies were significant for the following values: hemoglobin concentration, 5.6 g/dL (reference range, 12-15 g/dL); mean corpuscular volume, 116.9 μm3 (reference range, 80-100 μm3); and reticulocyte count, 16% (reference range, 0.5-1.5%). An elevated serum lactate dehydrogenase concentration (646 U/L [reference range, 50-150 U/L]) and a low haptoglobin concentration (<10 mg/dL [reference range, 30-200 mg/dL]) indicated a hemolytic process. A peripheral blood smear revealed spherocytosis. Serologic testing showed antibodies to both immunoglobulin G (IgG) and complement component C3b. An antibody identification panel was nonspecifically positive for a warm-reacting autoantibody (IgG). The combination of clinically evident hemolytic anemia, recent exposure to a newly initiated drug, and serologic evidence strongly suggested DIIHA. Trimethoprim-sulfamethoxazole was promptly discontinued, a total of 6 units of packed red blood cells were transfused, and the patient was treated with methylprednisolone sodium succinate. Clinical and hematologic improvements were observed within a few days. Results of follow-up antibody screening and direct antiglobulin testing 4 weeks after discharge were negative. Conclusion: A 58-year-old woman developed warm autoimmune hemolytic anemia after receiving trimethoprim-sulfamethoxazole for 5 days.
Herpes zoster of the face and neck, with paralysis, earache, dizziness and nausea (J. Ramsay Hunt syndrome).

C. Sheard,E. A. Felder

1955-02-01

Abstract:
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

Jun Yong,Freddy Frost,Dilip Nazareth,Martin Walshaw

DOI: https://doi.org/10.12688/f1000research.14505.1

2018-04-18

Abstract:Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation.

Effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid gel supplementation on muscle mass, strength, and power in resistance trained individuals

DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.

Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report

Model studies of hydrogen atom addition and abstraction processes involving ortho-, meta-, and para-benzynes.

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

A Unified DAQ Interconnection Network With Precise Time Synchronization

Cefazolin-induced hemolytic anemia in septic arthritis: A case report

Simulation model for wide-area multi-service passive radar coverage predictions

AD-A 201 35 0 Distribution Unlimited

[Surgical repair of secondary local defect after auricular reconstruction].

Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

[Drug-induced immune hemolytic anemia caused by cefmetazole]

Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review

Ceftriaxone-Induced Encephalopathy in a Patient With Chronic Kidney Disease

[Specialization in veterinary medicine].

[Mesenteric cystic lymphangioma in children. Apropos of a case revealed by anemia].

Drug-induced immune haemolytic anaemia caused by levofloxacin

Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use

Herpes zoster of the face and neck, with paralysis, earache, dizziness and nausea (J. Ramsay Hunt syndrome).

Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis